Albuvirtide

艾博韦泰

Report date: 2022/01/27 16:13:18
NME

Base Information

Drug NameAlbuvirtide
Drug Alias Name艾博卫泰LabuvirtideAikening艾可宁FB-006M
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionTransmembrane glycoprotein gp41 inhibitorsHIV fusion inhibitors
TargetsTransmembrane glycoprotein gp41
Therapy Area/IndicationsAcquired Immunodeficiency SyndromeHIV Infections
Global Approved IndicationsHIV Infections
Approved Indications in ChinaHIV Infections
Original Approved Country/TerritoryMainland China
Original Approved Date2018/05/23
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesFrontier Biotechnologies Inc
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesR-Pharm JscFrontier Biotechnologies Inc
Inactive CompaniesChongqing Frontier Biotechnologies Co Ltd
Active IndicationsHIV Infections
Inactive IndicationsAcquired Immunodeficiency Syndrome

Other Information

ATC CodeJ05A
Related LinksN/A